Cyclomics
We are a Dutch biotech specialized in advanced molecular diagnostics and DNA sequencing.
Using cutting-edge technologies like Nanopore sequencing and proprietary molecular assays, we focus on detecting and monitoring cancer through precise analysis of circulating tumor DNA from liquid biopsies.
Our innovative approach enables real-time, non-invasive cancer detection, providing critical insights into tumor dynamics and treatment efficacy. ​ We revolutionize cancer diagnostics and improve patient outcomes with highly sensitive and accurate genetic testing solutions.
​​
Cyclomics doesn't stop here!
Our consensus-sequencing technology can be applied to a variety of fields.
We deliver high-accuracy sequencing solutions wherever they are needed.
Liquid Biopsy
A liquid biopsy is a minimally invasive diagnostic procedure that analyzes blood or other body fluids to detect cancer and other diseases. Unlike traditional biopsies, which require tissue samples from the tumor, liquid biopsies don't need surgical procedures. Liquid biopsies identify and measure circulating tumor DNA (ctDNA) and other biomarkers, providing critical insights with less risk and discomfort for patients.
Consensus Sequencing
Consensus sequencing is an advanced molecular diagnostics technique involving sequencing a specific DNA region multiple times to accurately identify and confirm genetic variations. Consensus sequencing is particularly useful for applications requiring precise genetic information, such as cancer diagnostics, microbial analysis, and genetic research, ensuring that even low-frequency mutations are accurately detected and reported.
Multi-Omics & AI
Multi-omics and AI together represent a transformative approach in biomedical research and healthcare. Multi-omics integrates data from various biological layers to provide a holistic view of cellular functions and disease mechanisms. AI enhances this integration by efficiently analyzing and interpreting the complex, high-dimensional data, uncovering hidden patterns, and generating actionable insights.